| __timestamp | Madrigal Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 49315000 |
| Thursday, January 1, 2015 | 13392000 | 75043000 |
| Friday, January 1, 2016 | 9290000 | 83749000 |
| Sunday, January 1, 2017 | 7672000 | 122682000 |
| Monday, January 1, 2018 | 15293000 | 207761000 |
| Tuesday, January 1, 2019 | 22648000 | 284812000 |
| Wednesday, January 1, 2020 | 21864000 | 317875000 |
| Friday, January 1, 2021 | 37318000 | 282660000 |
| Saturday, January 1, 2022 | 48130000 | 451421000 |
| Sunday, January 1, 2023 | 108146000 | 481871000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of two prominent players: Sarepta Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc., from 2014 to 2023.
Sarepta Therapeutics has consistently outpaced Madrigal Pharmaceuticals in SG&A spending, reflecting its aggressive growth strategy. In 2023, Sarepta's expenses reached nearly 482 million, a staggering 880% increase from 2014. Meanwhile, Madrigal's expenses, though significantly lower, have shown a remarkable growth of 587% over the same period, peaking at approximately 108 million in 2023.
This trend highlights the differing strategies of these companies. While Sarepta invests heavily in its operations, Madrigal maintains a more conservative approach. Understanding these dynamics offers valuable insights into the financial health and strategic priorities of these biotech firms.
Who Optimizes SG&A Costs Better? Zoetis Inc. or Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or MannKind Corporation
Operational Costs Compared: SG&A Analysis of Madrigal Pharmaceuticals, Inc. and Xencor, Inc.